There are varying reports about how negotiations between the Red Sox and Cubs for general manager Theo Epstein have gone, but here’s something new: According to Bruce Levine of ESPN Chicago the initial asking price was Matt Garza.
Realistically that was never going to happen, but it wouldn’t be shocking if the Red Sox figured they might as well start the process by requesting one of the Cubs’ few good, relatively young big leaguers.
Last offseason Chicago gave up a ton to get Garza from Tampa Bay and he had a strong first season with the Cubs, throwing 198 innings with a 3.20 ERA and 197 strikeouts. He’s also just 27 years old and under team control through 2014, so … well, it just wasn’t gonna happen.
Assuming the negotiations for Epstein eventually lead to a deal expect the compensation to be a non-elite minor leaguer or two.
Clayton Kershaw had nothing left to prove when he exited the mound during his last Cactus League start on Friday. He finished camp with a 0.00 ERA, made all the more impressive after he extended his scoreless streak to 21 1/3 innings following 6 2/3 frames of one-hit ball against the Royals.
In six spring training starts this year, the Dodgers southpaw racked up 12 hits, four walks and 23 strikeouts. His velocity appeared to fluctuate between the high-80s and low-90s from start to start, but manager Dave Roberts told reporters that he expects Kershaw to get back up to the 93 m.p.h. range next week. Kershaw is tabbed for his eighth consecutive Opening Day start on Thursday.
The 30-year-old lefty is poised to enter his 11th season with the club in 2018. He went 18-4 in 27 starts last year and turned in a 2.31 ERA, 1.5 BB/9 and 10.4 SO/9 over 175 innings. He suffered his fair share of bumps and bruises along the way, including a lower back strain that required a five-week stay on the disabled list.
The Dodgers will open their season against the Giants on Thursday, March 29 at 7:08 PM ET. Given the sudden rash of injuries that hit the Giants’ rotation earlier today, Kershaw’s Opening Day opponent has not yet been announced.